1.Efficacy of a DNA Vaccine Carrying Eimeria maxima Gam56 Antigen Gene against Coccidiosis in Chickens.
Jinjun XU ; Yan ZHANG ; Jianping TAO
The Korean Journal of Parasitology 2013;51(2):147-154
To control coccidiosis without using prophylactic medications, a DNA vaccine targeting the gametophyte antigen Gam56 from Eimeria maxima in chickens was constructed, and the immunogenicity and protective effects were evaluated. The ORF of Gam56 gene was cloned into an eukaryotic expression vector pcDNA3.1(zeo)+. Expression of Gam56 protein in COS-7 cells transfected with recombinant plasmid pcDNA-Gam56 was confirmed by indirect immunofluorescence assay. The DNA vaccine was injected intramuscularly to yellow feathered broilers of 1-week old at 3 dosages (25, 50, and 100 microg/chick). Injection was repeated once 1 week later. One week after the second injection, birds were challenged orally with 5x10(4) sporulated oocysts of E. maxima, then weighed and killed at day 8 post challenge. Blood samples were collected and examined for specific peripheral blood lymphocyte proliferation activity and serum antibody levels. Compared with control groups, the administration of pcDNA-Gam56 vaccine markedly increased the lymphocyte proliferation activity (P<0.05) at day 7 and 14 after the first immunization. The level of lymphocyte proliferation started to decrease on day 21 after the first immunization. A similar trend was seen in specific antibody levels. Among the 3 pcDNA-Gam56 immunized groups, the median dosage group displayed the highest lymphocyte proliferation and antibody levels (P<0.05). The median dosage group had the greatest relative body weight gain (89.7%), and the greatest oocyst shedding reduction (53.7%). These results indicate that median dosage of DNA vaccine had good immunogenicity and immune protection effects, and may be used in field applications for coccidiosis control.
Animals
;
Antibodies, Protozoan/blood
;
Antigens, Protozoan/genetics/*immunology
;
Cell Proliferation
;
Chickens
;
Coccidiosis/immunology/pathology/*prevention & control
;
Disease Models, Animal
;
Eimeria/genetics/*immunology
;
Injections, Intramuscular
;
Lymphocytes/immunology
;
Protozoan Vaccines/administration & dosage/genetics/*immunology
;
Vaccination/methods
;
Vaccines, DNA/administration & dosage/genetics/*immunology
2.CD8+ T-cell Activation in Mice Injected with a Plasmid DNA Vaccine Encoding AMA-1 of the Reemerging Korean Plasmodium vivax.
Hyo Jin KIM ; Bong Kwang JUNG ; Jin Joo LEE ; Kyoung Ho PYO ; Tae Yun KIM ; Byung il CHOI ; Tae Woo KIM ; Hajime HISAEDA ; Kunisuke HIMENO ; Eun Hee SHIN ; Jong Yil CHAI
The Korean Journal of Parasitology 2011;49(1):85-90
Relatively little has been studied on the AMA-1 vaccine against Plasmodium vivax and on the plasmid DNA vaccine encoding P. vivax AMA-1 (PvAMA-1). In the present study, a plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax has been constructed and a preliminary study was done on its cellular immunogenicity to recipient BALB/c mice. The PvAMA-1 gene was cloned and expressed in the plasmid vector UBpcAMA-1, and a protein band of approximately 56.8 kDa was obtained from the transfected COS7 cells. BALB/c mice were immunized intramuscularly or using a gene gun 4 times with the vaccine, and the proportions of splenic T-cell subsets were examined by fluorocytometry at week 2 after the last injection. The spleen cells from intramuscularly injected mice revealed no significant changes in the proportions of CD8+ T-cells and CD4+ T-cells. However, in mice immunized using a gene gun, significantly higher (P<0.05) proportions of CD8+ cells were observed compared to UB vector-injected control mice. The results indicated that cellular immunogenicity of the plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax was weak when it was injected intramuscularly; however, a promising effect was observed using the gene gun injection technique.
Animals
;
Antigens, Protozoan/administration & dosage/genetics/*immunology
;
CD8-Positive T-Lymphocytes/*immunology
;
COS Cells
;
Cercopithecus aethiops
;
Humans
;
Lymphocyte Activation
;
Malaria, Vivax/*immunology/parasitology
;
Membrane Proteins/administration & dosage/genetics/*immunology
;
Mice
;
Mice, Inbred BALB C
;
Plasmodium vivax/genetics/*immunology
;
Protozoan Proteins/administration & dosage/genetics/*immunology
;
Protozoan Vaccines/administration & dosage/genetics/*immunology
;
Vaccines, DNA/administration & dosage/genetics/*immunology
3.A Novel Recombinant BCG Vaccine Encoding Eimeria tenella Rhomboid and Chicken IL-2 Induces Protective Immunity Against Coccidiosis.
Qiuyue WANG ; Lifeng CHEN ; Jianhua LI ; Jun ZHENG ; Ning CAI ; Pengtao GONG ; Shuhong LI ; He LI ; Xichen ZHANG
The Korean Journal of Parasitology 2014;52(3):251-256
A novel recombinant Bacille Calmette-Guerin (rBCG) vaccine co-expressed Eimeria tenella rhomboid and cytokine chicken IL-2 (chIL-2) was constructed, and its efficacy against E. tenella challenge was observed. The rhomboid gene of E. tenella and chIL-2 gene were subcloned into integrative expression vector pMV361, producing vaccines rBCG pMV361-rho and pMV361-rho-IL2. Animal experiment via intranasal and subcutaneous route in chickens was carried out to evaluate the immune efficacy of the vaccines. The results indicated that these rBCG vaccines could obviously alleviate cacal lesions and oocyst output. Intranasal immunization with pMV361-rho and pMV361-rho-IL2 elicited better protective immunity against E. tenella than subcutaneous immunization. Splenocytes from chickens immunized with either rBCG pMV361-rho and pMV361-rho-IL2 had increased CD4+ and CD8+ cell production. Our data indicate recombinant BCG is able to impart partial protection against E. tenella challenge and co-expression of cytokine with antigen was an effective strategy to improve vaccine immunity.
Adjuvants, Immunologic/genetics/*metabolism
;
Administration, Intranasal
;
Animals
;
Antigens, Protozoan/genetics/*immunology
;
BCG Vaccine/administration & dosage/*genetics
;
CD4-Positive T-Lymphocytes/immunology
;
CD8-Positive T-Lymphocytes/immunology
;
Chickens
;
Coccidiosis/*prevention & control
;
Disease Models, Animal
;
Drug Carriers/administration & dosage
;
Eimeria tenella/genetics/*immunology
;
Genetic Vectors
;
Injections, Subcutaneous
;
Interleukin-2/genetics/*metabolism
;
Protozoan Vaccines/administration & dosage/genetics/*immunology
;
Spleen/immunology
;
Vaccines, Synthetic/administration & dosage/genetics/immunology